SCHEMBL4333979

SCHEMBL4333979

CSCCNC(=O)c1cc(C)c2[nH]nc(-c3cccc(F)c3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
TP53 P04637 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 1/20 0.38
NPY1R P25929 1/20 0.38
RECQL P46063 1/20 0.38
NPY2R P49146 1/20 0.38
TTK P33981 1/20 0.38
MAP2K4 P45985 1/20 0.38
MAPK1 P28482 4/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.38
MAP4K4 O95819 1/20 0.37
GRK6 P43250 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334999 0.92 TP53 (0.41) MAPTTP53SMN1; SMN2MAP2K4MAPK1
SCHEMBL4332230 0.89 MAPT (0.44) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL4336321 0.82 MAPK1 (0.43) MAPTTP53TTKMAP2K4MAPK1
SCHEMBL2860005 0.81 DYRK1A (0.48) MAP2K4L3MBTL1MAP4K4
SCHEMBL4334969 0.80 TTK (0.54) MAPTTP53SMN1; SMN2KDM4ETTK
SCHEMBL4336101 0.80 HPGD (0.57) SMN1; SMN2KDM4ERECQLMAPK1NPC1
SCHEMBL4334638 0.80 HPGD (0.42) MAPTTP53SMN1; SMN2KDM4ETTK
SCHEMBL2862110 0.79 MAP2K4 (0.55) MAP2K4MAPK1GRK6
SCHEMBL4334329 0.78 NPC1 (0.41) MAPTTP53SMN1; SMN2MAPK1NPC1
SCHEMBL4336397 0.78 HPGD (0.61) TP53SMN1; SMN2KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPT 2644/4885TP53 1560/4885SMN1; SMN2 4812/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPT 2644/4885TP53 1560/4885SMN1; SMN2 4812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.